Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury
Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury is a paper indexed in PICO Portal from OpenAlex.
How many citations does Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury have?
Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury has 109 citations in the OpenAlex counts PICO Portal stores.
When was Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury published?
Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury has 2009 year in the PICO Portal index.
What is the open-access status of Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury?
Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury has closed oa status in the PICO Portal index.
What is the DOI of Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury?
The DOI for Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury is on the source record.
What is the PMID of Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury?
The PMID for Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury is on the source record.
What is the OpenAlex record for Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury?
The OpenAlex for Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury is on the source record.